Cardinal Health Raises 2026 Profit Forecast Due to Strong Demand for Specialty Drugs
Cardinal Health has raised its 2026 adjusted profit forecast to $10.70–$10.80 per share, driven by strong demand for specialty drugs and branded medications. The company's third-quarter profit exceeded expectations, though total sales fell slightly short of estimates. The pharmaceuticals unit, which accounts for a large portion of revenue, saw an 11% year-over-year sales increase.
Topics: Drug Distributors Earnings Report Pharmaceuticals Profit Forecast Specialty Drugs